Naoki Nishida

Dr. Naoki Nishida

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2000 in Stroke
Verified
Journal Article
Closed access
PDF file
SKSetsuko Kuroda
Setsuko Kuroda
NNNaoki Nishida
Naoki Nishida
TUTakashi Uzu
Takashi Uzu
MTMasanobu Takeji
Masanobu Takeji
MNMasataka Nishimura
Masataka Nishimura
GKGenjiro Kimura
Genjiro Kimura
Background and Purpose —Atherosclerotic renal artery stenosis commonly exists as one manifestation of more generalized atherosclerosis. It is a progressive but potentially curable disorder. Thus, information on renal artery involvement in atherosclerotic diseases could be important. We investigated the prevalence of renal artery stenosis in autopsied patients with stroke over 40 years of age. Methods —From 2167 consecutive autopsy patients who died between 1980 and 1997, we studied 346 cases of mean age of 69±11 years with clinical evidence of stroke. Results —Atherosclerotic renal artery stenosis (≥75% luminal area narrowing) was found in 36 patients (10.4%). Patients with renal artery stenosis were older and had worse renal function. Renal artery stenosis was found in 14.7%, 28.6%, and 23.9% of patients with hypertension, renal insufficiency, and aortic aneurysm, respectively. Extracranial carotid artery stenosis (>50% luminal area narrowing) was found in 101 patients (29.2%). Of the 346 stroke patients, 256 had a history of brain infarction. In patients with brain infarction, renal artery stenosis was found in 31 (12.1%) and carotid stenosis was found in 81 (33.6%). Patients with carotid artery stenosis were more likely to have renal artery stenosis than patients without carotid artery stenosis (24.4% versus 5.9%, P <0.0001). Multiple logistic regression analysis identified renal insufficiency, hypertension, female gender, and presence of carotid artery stenosis as independent predictors of renal artery stenosis in patients with brain infarction. Conclusions —These data reveal that atherosclerotic renal artery stenosis is common in patients with stroke, especially in those with brain infarction.

7 January 2017 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
KYKoji Yoshida
Koji Yoshida
YHYukiko Hata
Yukiko Hata
KKKoshi Kinoshita
Koshi Kinoshita
STShutaro Takashima
Shutaro Takashima
KTKortaro Tanaka
Kortaro Tanaka
NNNaoki Nishida
Naoki Nishida

1 May 2005 in Forensic Science International
Verified
Journal Article
Closed access
TCTakashi Chiba
Takashi Chiba
MYMisa Yamauchi
Misa Yamauchi
NNNaoki Nishida
Naoki Nishida
TKTaeko Kaneko
Taeko Kaneko
KYKatsuaki Yoshizaki
Katsuaki Yoshizaki
NYNaofumi Yoshioka
Naofumi Yoshioka

1 July 2016 in Heart Rhythm
Verified
Journal Article
Closed access
YHYukiko Hata
Yukiko Hata
KKKoshi Kinoshita
Koshi Kinoshita
KMKoichi Mizumaki
Koichi Mizumaki
YYYoshiaki Yamaguchi
Yoshiaki Yamaguchi
KHKeiichi Hirono
Keiichi Hirono
NNNaoki Nishida
Naoki Nishida

22 September 2017 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
CWCe Wang
Ce Wang
YHYukiko Hata
Yukiko Hata
KHKeiichi Hirono
Keiichi Hirono
ATAsami Takasaki
Asami Takasaki
SOSayaka Watanabe Ozawa
Sayaka Watanabe Ozawa
FCfor LVNC Study Collaborators
for LVNC Study Collaborators
Background: Left ventricular noncompaction ( LVNC ) has since been classified as a primary genetic cardiomyopathy, but the genetic basis is not fully evaluated. The aim of the present study was to identify the genetic spectrum using next‐generation sequencing and to evaluate genotype–phenotype correlations in LVNC patients. Methods and Results: Using next‐generation sequencing, we targeted and sequenced 73 genes related to cardiomyopathy in 102 unrelated LVNC patients. We identified 43 pathogenic variants in 16 genes in 39 patients (38%); 28 were novel variants. Sarcomere gene variants accounted for 63%, and variants in genes associated with channelopathies accounted for 12%. MYH7 and TAZ pathogenic variants were the most common, and rare variant collapsing analysis showed variants in these genes contributed to the risk of LVNC , although patients carrying MYH7 and TAZ pathogenic variants displayed different phenotypes. Patients with pathogenic variants had early age of onset and more severely decreased left ventricular ejection fractions. Survival analysis showed poorer prognosis in patients with pathogenic variants, especially those with multiple variants: All died before their first birthdays. Adverse events were noted in 17 patients, including 13 deaths, 3 heart transplants, and 1 implantable cardioverter‐defibrillator insertion. Congestive heart failure at diagnosis and pathogenic variants were independent risk factors for these adverse events. Conclusions: Next‐generation sequencing revealed a wide spectrum of genetic variations and a high incidence of pathogenic variants in LVNC patients. These pathogenic variants were independent risk factors for adverse events. Patients harboring pathogenic variants showed poor prognosis and should be followed closely.

20 June 2016 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
YHYukiko Hata
Yukiko Hata
KYKoji Yoshida
Koji Yoshida
KKKoshi Kinoshita
Koshi Kinoshita
NNNaoki Nishida
Naoki Nishida